Search

everythinglearnresearchcommunity

for

Search:↓

Black cumin and its nanoformulations show promise in treating neurodegenerative diseases.

Blood AMH levels are higher in women with PCOS than in those with other similar conditions.

Antiandrogens can treat female hormonal conditions, but environmental ones may harm reproductive health.

Finasteride negatively affects fish reproduction and gonadal development.

Combining lifestyle changes and medication is most effective for managing PCOS symptoms.

Topical vitamin D is effective in treating vitiligo with few side effects.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Fibroblast changes in systemic sclerosis may help understand disease severity and treatment.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Hormones, especially testosterone and DHT, are key for penis development and function, and testosterone therapy may help with erectile dysfunction in those with low levels.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Birth control pills change the activity of certain inflammation and blood clotting genes in women with PCOS.

Chronic stress in mice changes skin metabolism and gene expression, leading to hair loss.

Finasteride doesn't affect omeprazole metabolism in Japanese people.

Some plants with flavonoids may help treat hair loss and promote hair growth.

Diagnosing hyperandrogenism in women is complex and requires accurate testing methods and consideration of SHBG levels.

The European Society of Endocrinology advises individualized long-term management for PCOS, focusing on lifestyle changes, accurate diagnosis, and treatments for associated health risks and symptoms.

HIF-1α stimulators, like deferiprone, work as well as popular hair loss treatments, minoxidil and caffeine, in promoting hair growth.

Women with Polycystic Ovary Syndrome (PCOS) have lower levels of a substance called DIAPH1 in their blood, which is linked to changes in sugar metabolism and insulin resistance.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

Hair color production in mice is closely linked to the hair growth phase and may also influence hair growth itself.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Finasteride can have lasting negative effects on brain function and behavior by disrupting neurosteroid production.

Metformin helps manage polycystic ovary syndrome by improving insulin resistance and ovulation, but more research is needed on its full effects.

Testosterone significantly affects sexual desire in both men and women, but its impact on women is more complex and influenced by psychological factors.

The document concludes that proper diagnosis and combined treatments are key for hirsutism management, and weight loss may help overweight patients.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

C60 fullerenes can alter protein function and may help develop new disease inhibitors.

Young girls whose mothers have PCOS may have higher activity of a specific enzyme that could lead to developing PCOS later.

TCDD speeds up skin barrier formation by increasing certain gene expressions.